ID

15848

Description

R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00135499

Lien

https://clinicaltrials.gov/show/NCT00135499

Mots-clés

  1. 15/06/2016 15/06/2016 -
Téléchargé le

15 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lymphoma, Large-Cell, Diffuse NCT00135499

Eligibility Lymphoma, Large-Cell, Diffuse NCT00135499

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient with diffuse large b-cell lymphoma according to the who classification (anti cd20 labeling)
Description

diffuse large b-cell lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0079744
aged from 60 to 65 years.
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
not previously treated.
Description

previous treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
ann arbor stage ii, iii, iv.
Description

ann arbor stage

Type de données

boolean

Alias
UMLS CUI [1]
C0432516
ecog performance status 0 to 2.
Description

ecog performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
minimum life expectancy of 3 months.
Description

life expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
negative hiv, hepatitis b virus (hbv) and hepatitis c virus (hcv) serologies test  4 weeks (except after vaccination).
Description

serologies test

Type de données

boolean

Alias
UMLS CUI [1]
C0019698
UMLS CUI [2]
C0853319
UMLS CUI [3]
C0201485
having previously signed a written informed consent.
Description

written informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
t-cell lymphoma.
Description

t-cell lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0079772
any history of treated or non-treated indolent lymphoma. however, patients not previously diagnosed and having a diffuse large b-cell lymphoma with some small cell infiltration in bone marrow or lymph node may be included.
Description

indolent lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C1334170
central nervous system or meningeal involvement by lymphoma.
Description

central nervous system involvement

Type de données

boolean

Alias
UMLS CUI [1]
C0449389
UMLS CUI [2]
C2213017
contra-indication to any drug contained in the chemotherapy regimens.
Description

contraindication chemotherapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0392920
any serious active disease (according to the investigator’s decision).
Description

serious active disease

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
poor renal function (creatinine level>150micromol/l), poor hepatic function (total bilirubin level>30mmol/l, transaminases>2.5 maximum normal level) unless these abnormalities are related to the lymphoma.
Description

abnormalities

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0002594
poor bone marrow reserve as defined by neutrophils<1.5g/l or platelets<100g/l, unless related to bone marrow infiltration.
Description

poor bone marrow reserve

Type de données

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0005821
any history of cancer during the last 5 years with the exception of non-melanoma skin tumors or stage 0 (in situ) cervical carcinoma.
Description

history of cancer

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
treatment with any investigational drug within 30 days before planned first cycle of chemotherapy and during the study.
Description

investigational drug

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
adult patient under tutelage.
Description

tutelage

Type de données

boolean

Similar models

Eligibility Lymphoma, Large-Cell, Diffuse NCT00135499

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
diffuse large b-cell lymphoma
Item
patient with diffuse large b-cell lymphoma according to the who classification (anti cd20 labeling)
boolean
C0079744 (UMLS CUI [1])
age
Item
aged from 60 to 65 years.
boolean
C0001779 (UMLS CUI [1])
previous treatment
Item
not previously treated.
boolean
C0087111 (UMLS CUI [1])
ann arbor stage
Item
ann arbor stage ii, iii, iv.
boolean
C0432516 (UMLS CUI [1])
ecog performance status
Item
ecog performance status 0 to 2.
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
minimum life expectancy of 3 months.
boolean
C0023671 (UMLS CUI [1])
serologies test
Item
negative hiv, hepatitis b virus (hbv) and hepatitis c virus (hcv) serologies test  4 weeks (except after vaccination).
boolean
C0019698 (UMLS CUI [1])
C0853319 (UMLS CUI [2])
C0201485 (UMLS CUI [3])
written informed consent
Item
having previously signed a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
t-cell lymphoma
Item
t-cell lymphoma.
boolean
C0079772 (UMLS CUI [1])
indolent lymphoma
Item
any history of treated or non-treated indolent lymphoma. however, patients not previously diagnosed and having a diffuse large b-cell lymphoma with some small cell infiltration in bone marrow or lymph node may be included.
boolean
C1334170 (UMLS CUI [1])
central nervous system involvement
Item
central nervous system or meningeal involvement by lymphoma.
boolean
C0449389 (UMLS CUI [1])
C2213017 (UMLS CUI [2])
contraindication chemotherapy
Item
contra-indication to any drug contained in the chemotherapy regimens.
boolean
C1301624 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
serious active disease
Item
any serious active disease (according to the investigator’s decision).
boolean
C0009488 (UMLS CUI [1])
abnormalities
Item
poor renal function (creatinine level>150micromol/l), poor hepatic function (total bilirubin level>30mmol/l, transaminases>2.5 maximum normal level) unless these abnormalities are related to the lymphoma.
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0002594 (UMLS CUI [3])
poor bone marrow reserve
Item
poor bone marrow reserve as defined by neutrophils<1.5g/l or platelets<100g/l, unless related to bone marrow infiltration.
boolean
C0948762 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
history of cancer
Item
any history of cancer during the last 5 years with the exception of non-melanoma skin tumors or stage 0 (in situ) cervical carcinoma.
boolean
C0006826 (UMLS CUI [1])
investigational drug
Item
treatment with any investigational drug within 30 days before planned first cycle of chemotherapy and during the study.
boolean
C2348568 (UMLS CUI [1])
tutelage
Item
adult patient under tutelage.
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial